World's Best Scientists 2026 revealed!
Gert Van Assche

Gert Van Assche

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 113 4851 4551 50 47 765 63749

Gert Van Assche publications per year

The chart shows the history of publications by Gert Van Assche between 1995 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Gert Van Assche published across 30 years, from 1995 to 2024, averaging 26 papers a year. Output peaked at 73 publications in 2015. 1 of the 780 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1995 to 2024. Vertical axis: number of publications, 0 to 73. Peak 73 publications in 2015. 1995: 2 publications 1996: 0 publications 1997: 2 publications 1998: 4 publications 1999: 3 publications 2000: 8 publications 2001: 13 publications 2002: 9 publications 2003: 15 publications 2004: 20 publications 2005: 17 publications 2006: 22 publications 2007: 31 publications 2008: 44 publications 2009: 36 publications 2010: 43 publications 2011: 31 publications 2012: 62 publications 2013: 45 publications 2014: 58 publications 2015: 73 publications 2016: 53 publications 2017: 50 publications 2018: 69 publications 2019: 46 publications 2020: 16 publications 2021: 5 publications 2022: 2 publications 2023: 0 publications 2024: 1 publication
1995 2024

780 publications in total across all disciplines

View publications per year as a table
Gert Van Assche: publications per year, 1995 to 2024
Year Publications
1995 2
1996 0
1997 2
1998 4
1999 3
2000 8
2001 13
2002 9
2003 15
2004 20
2005 17
2006 22
2007 31
2008 44
2009 36
2010 43
2011 31
2012 62
2013 45
2014 58
2015 73
2016 53
2017 50
2018 69
2019 46
2020 16
2021 5
2022 2
2023 0
2024 1
Total 780
Download as CSV

Gert Van Assche publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gert Van Assche sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 761–780 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 765 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228 765
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Gert Van Assche D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gert Van Assche sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 112–113 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399 113
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Gert Van Assche is affiliated with KU Leuven in Belgium and has a research profile strongly focused on inflammatory and autoimmune disorders, particularly inflammatory bowel disease (IBD). Their work spans several interconnected fields including medicine, biochemistry, genetics, and molecular biology.

The scientist's research output features a considerable emphasis on subfields such as genetics, epidemiology, surgery, immunology, and molecular biology. This multidisciplinary approach underpins investigations into complex disease mechanisms and treatment strategies.

Several main topics characterize their research:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Autoimmune and Inflammatory Disorders
  • IL-33, ST2, and ILC Pathways
  • Eosinophilic Esophagitis
  • Pharmacological Effects of Natural Compounds
  • Gastrointestinal Bleeding Diagnosis and Treatment

Gert Van Assche has contributed to numerous scientific publications, including recent papers such as:

  • "Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease" (2020), published in Gastroenterology
  • "Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update" (2020), published in Digestion
  • "Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies" (2020), published in Clinical Gastroenterology and Hepatology
  • "A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis" (2020), published in Inflammatory Intestinal Diseases
  • "Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium" (2020), published in Frontiers in Immunology

The publication venues where the scientist frequently publishes include:

  • Journal of Crohn's and Colitis
  • Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • Inflammatory Intestinal Diseases
  • Scandinavian Journal of Gastroenterology

Collaborative work plays a significant role in Gert Van Assche's research, with frequent co-authors being:

  • Séverine Vermeire
  • Marc Ferrante
  • Gert De Hertogh
  • Brecht Creyns
  • Jan Ceuppens

Best Publications

  • Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease.

    Filip Baert;Maja Noman;Severine Vermeire;Gert Van Assche

  • Vedolizumab as induction and maintenance therapy for ulcerative colitis.

    Brian G Feagan;Paul Rutgeerts;Bruce E Sands;Stephen Hanauer

  • 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Fernando Gomollón;Axel Dignass;Vito Annese;Herbert Tilg

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

    Marco Daperno;Geert D'Haens;Gert Van Assche;Filip Baert

  • Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

    Geert D'Haens;Filip Baert;Gert van Assche;Philip Caenepeel

  • Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

    Axel Dignass;James O. Lindsay;Andreas Sturm;Alastair Windsor

  • Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    William J. Sandborn;Gert van Assche;Walter Reinisch;Jean–Frederic Colombel

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

    Gert Van Assche;Axel Dignass;Julian Panes;Laurent Beaugerie

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

    Gert Van Assche;Axel Dignass;Walter Reinisch;C. Janneke van der Woude

  • Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease

    Gert Van Assche;Marc Van Ranst;Raphael Sciot;Bénédicte Dubois

  • Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 1: Definitions and Diagnosis

    Axel Dignass;Rami Eliakim;Fernando Magro;Christian Maaser

  • Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

    Julián Panés;Damián García-Olmo;Gert Van Assche;Jean Frederic Colombel

  • Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Geert D'Haens;Marc Ferrante;Severine Vermeire;Filip Baert

  • Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.

    Filip Baert;Liesbeth Moortgat;Gert Van Assche;Philip Caenepeel

  • Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

    Niels Vande Casteele;Marc Ferrante;Gert Van Assche;Vera Ballet

  • Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease

    Severine Vermeire;Maja Noman;Gert van Assche;Filip Baert

  • Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

    Fabian Schnitzler;Herma Fidder;Marc Ferrante;Maja Noman

  • Development of the Crohn's disease digestive damage score, the Lémann score†‡§

    Benjamin Pariente;Jacques Cosnes;Silvio Danese;William J. Sandborn

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

    David Laharie;Arnaud Bourreille;Julien Branche;Matthieu Allez

Frequent Co-Authors

Jan Ceuppens
Jan Ceuppens KU Leuven
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
William J. Sandborn
William J. Sandborn University of California, San Diego
Karel Geboes
Karel Geboes Ghent University Hospital
Frans Schuit
Frans Schuit KU Leuven
Walter Reinisch
Walter Reinisch Medical University of Vienna
Julián Panés
Julián Panés University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary pathways in healthcare is a smart move for those interested in studying Medicine in the USA. Online degrees now make it easier to advance your career while managing costs and maintaining flexibility.

A popular choice is a mha degree cost-effective program, which prepares graduates for management and leadership roles in healthcare organizations. Another option is to explore the cheapest dnp programs, offering advanced practice and specialized clinical opportunities for nurses looking to achieve the highest level of nursing practice.

For those interested in pharmaceutical sciences, pursuing an online pharmacist degree can open doors to clinical, research, and retail settings. Additionally, the growing field of health informatics presents robust career opportunities—earning a him degree online is ideal for those interested in managing patient data and healthcare information systems.

These online programs offer flexible schedules, accessibility, and often lower tuition costs, making them attractive options for diverse career goals in the healthcare sector.

Best Scientists Citing Gert Van Assche

Trending Scientists

Recently Published Articles